Related Experiment Videos

Fever without source in children 0 to 36 months of age

Paul Ishimine1

  • 1Department of Emergency Medicine, University of California, San Diego Medical Center, 92103-8676, USA. pishimin@ucsd.edu

Pediatric Clinics of North America
|April 1, 2006
PubMed

Insights

Fever in young children requires careful evaluation, especially after pneumococcal conjugate vaccine (PCV7) introduction altered disease patterns. This guide details approaches for neonates, infants, and toddlers up to 36 months old.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Fever in young children (0-36 months) is a frequent clinical challenge with ongoing debate regarding optimal evaluation and management strategies.
  • The widespread adoption of the heptavalent pneumococcal conjugate vaccine (PCV7) has significantly impacted the epidemiology of invasive bacterial infections in this age group.
  • Current clinical guidelines need to reflect these epidemiological shifts for effective patient care.

Purpose of the Study:

  • To outline a structured approach for evaluating and managing febrile neonates (0-28 days), young infants (1-3 months), and older infants and toddlers (3-36 months).
  • To provide evidence-based recommendations tailored to the post-PCV7 vaccination era.
  • To address the controversies surrounding fever management in young children.

Main Methods:

  • Review of current literature and clinical guidelines.
  • Analysis of epidemiological data on invasive bacterial disease in the PCV7 era.
  • Synthesis of recommendations for different age strata (neonates, young infants, older infants/toddlers).

Main Results:

  • The PCV7 vaccine has reduced the incidence of invasive pneumococcal disease, altering the differential diagnosis for febrile illnesses.
  • Specific diagnostic and management pathways are proposed for neonates, young infants, and older children based on age and clinical presentation.
  • Emphasis on careful assessment to differentiate serious bacterial infections from self-limiting febrile illnesses.

Conclusions:

  • A nuanced approach to febrile young children is essential in the PCV7 era, considering age-specific risks and changing disease epidemiology.
  • Standardized evaluation protocols can improve the timely diagnosis and treatment of serious infections.
  • Continued vigilance and adaptation of clinical practice are necessary to optimize outcomes for febrile children.

Related Concept Videos

Types of Fever01:25

Types of Fever

Fever can be triggered by several factors, including infections, nervous system disorders, certain cancers, blood diseases like leukemia, embolism, thrombosis, heatstroke, dehydration, surgical trauma, crushing injuries, and allergic reactions.
Here are the different types of fever:
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in response to an infection or illness.
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Patterns of Fever01:26

Patterns of Fever

Before understanding the types and patterns of fever, it is essential to know its phases.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...